Filter by: patients
What is Interferon beta-1b SubQ Injection?

Interferon beta-1b is a drug in the interferon family used to treat multiple sclerosis. It is administered by sub-cutaneous injection and has been shown to slow the advance of the affliction as well as reduce the frequency of attacks.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 1379 412 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 22 5 Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
General health 13 7 Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Fatigue 11 5 Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Walking problems 8 2 Efficacy_moderate Efficacy_cant_tell
Stiffness/Spasticity 7 2 Efficacy_slight

See all 995 patients currently taking Interferon beta-1b SubQ Injection

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
75
Moderate
123
Mild
166
None
70

Commonly reported side effects, conditions, and hospitalizations associated with Interferon beta-1b SubQ Injection

Flu like symptoms 132
Injection site pain 87
Bruising 71
Headaches 60
Feel lousy 57
Depressed mood 49
See all 142 reported side effects See top 6 reported side effects

Reported Dosages

Frequently reported dosages based on patients currently taking Interferon beta-1b SubQ Injection. See all 97 dosages

  weekly 0.075 mg every other day 0.3 mg weekly 0.25 mg 0.3 mg 0.3 mg every other day 0.3 mg daily 1 mg every other day 1 mg 1 mg daily
  8 Number of Patients: 8 8 Number of Patients: 8 11 Number of Patients: 11 9 Number of Patients: 9 42 Number of Patients: 42 597 Number of Patients: 597 79 Number of Patients: 79 25 Number of Patients: 25 21 Number of Patients: 21 8 Number of Patients: 8  

Reported Stop Reasons

Why Patients Stopped Taking Interferon beta-1b SubQ Injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 290   Side effects too severe: 38%
Did not seem to work 261   Did not seem to work: 35%
Doctor's advice 260   Doctor's advice: 34%
Other 136   Other: 18%
Expense 27   Expense: 4%
Change in health plan coverage 25   Change in health plan coverage: 3%
Course of treatment ended 17   Course of treatment ended: 2%
Personal research 16   Personal research: 2%
Not indicated 12   Not indicated: 2%

See all 727 patients who’ve stopped taking Interferon beta-1b SubQ Injection

Currently Taking Interferon beta-1b SubQ Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Interferon beta-1b SubQ Injection

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Interferon beta-1b SubQ Injection

Always
326 75%
Usually
86 20%
Sometimes
8 2%
Never
14 3%

Burden

Difficulty being on treatment

Burden of Interferon beta-1b SubQ Injection

Very
43 10%
Somewhat
128 29%
A little
149 34%
Not at all
114 26%

Cost

Paid out of pocket

Cost of Interferon beta-1b SubQ Injection

$200+
28 9%
$100-199
18 5%
$50-99
54 16%
$25-49
77 23%
< $25
149 45%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.